A Study of Metastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene Encoding the Intracellular Immune Checkpoint CISH Is Inhibited Using CRISPR Genetic Engineering
Intima Bioscience, Inc.
Intima Bioscience, Inc.
Elicio Therapeutics
Merck Sharp & Dohme LLC
Leap Therapeutics, Inc.
TransThera Sciences (Nanjing), Inc.
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Ohio State University Comprehensive Cancer Center
TransThera Sciences (Nanjing), Inc.
National Cancer Institute (NCI)
University of Nebraska
University of Nebraska
European Organisation for Research and Treatment of Cancer - EORTC
EMD Serono
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Mayo Clinic
Mayo Clinic
M.D. Anderson Cancer Center
AIO-Studien-gGmbH
University of Chicago
The Christie NHS Foundation Trust
Wake Forest University Health Sciences
MacroGenics
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
H. Lee Moffitt Cancer Center and Research Institute
Fuda Cancer Hospital, Guangzhou
H. Lee Moffitt Cancer Center and Research Institute
ASLAN Pharmaceuticals
Govind Ballabh Pant Institute of Postgraduate Medical Education and Research
ASLAN Pharmaceuticals
Eli Lilly and Company
Abramson Cancer Center at Penn Medicine
University of Chicago
Canadian Cancer Trials Group
The Christie NHS Foundation Trust
University of Pittsburgh
Xuzhou Central Hospital
Montefiore Medical Center
SWOG Cancer Research Network
SWOG Cancer Research Network
National Cancer Institute (NCI)
Vanderbilt-Ingram Cancer Center
Mayo Clinic
Roswell Park Cancer Institute
UNICANCER
Peking University
Alliance for Clinical Trials in Oncology